These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2161706)

  • 1. Individual and combined usefulness of lipid associated sialic acid, mucoid proteins and hexoses as tumor markers in breast carcinoma.
    Patel PS; Baxi BR; Adhvaryu SG; Balar DB
    Cancer Lett; 1990 Jun; 51(3):203-8. PubMed ID: 2161706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of serum sialoglycoproteins in patients with lung cancer.
    Patel PS; Baxi BR; Balar DB
    Neoplasma; 1989; 36(1):53-9. PubMed ID: 2539569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The utility of lipid-associated sialic acid (LASA or LSA) as a serum marker for malignancy. A review of the literature.
    Schutter EM; Visser JJ; van Kamp GJ; Mensdorff-Pouilly S; van Dijk W; Hilgers J; Kenemans P
    Tumour Biol; 1992; 13(3):121-32. PubMed ID: 1626178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of serum sialic acid, heat stable alkaline phosphatase and fucose as markers of breast carcinoma.
    Patel PS; Baxi BR; Adhvaryu SG; Balar DB
    Anticancer Res; 1990; 10(4):1071-4. PubMed ID: 2382978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seromucoid fraction: a useful biomarker for patients with breast cancer.
    Patel PS; Patel MM; Raval GN; Rawal RM; Balar DB; Patel DD
    Am J Clin Oncol; 1998 Jun; 21(3):258-62. PubMed ID: 9626794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer and family history: levels of lipid-associated sialic acid in plasma and absent family history of breast cancer in women who have breast tumors.
    Brower ST; Tartter P; Weiss S; Luderer AA; Lehrer S
    Mt Sinai J Med; 1995 Nov; 62(6):419-21. PubMed ID: 8692154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of serum glycoconjugates in precancerous and cancerous diseases of the oral cavity.
    Baxi BR; Patel PS; Adhvaryu SG; Dayal PK
    Cancer; 1991 Jan; 67(1):135-40. PubMed ID: 1985709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total and lipid-bound serum sialic acid in benign and malignant breast disease.
    Romppanen J; Eskelinen M; Tikanoja S; Mononen I
    Anticancer Res; 1997; 17(2B):1249-53. PubMed ID: 9137482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid-associated sialic acid, squamous cell carcinoma antigen, carcinoembryonic antigen, and lactic dehydrogenase levels as tumor markers in squamous cell carcinoma of the head and neck.
    Dreyfuss AI; Clark JR; Andersen JW
    Cancer; 1992 Nov; 70(10):2499-503. PubMed ID: 1423179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of sialic acid concentrations in serum for the diagnosis and staging of breast cancer.
    Riley WM; Tautu C; Verazin G; Gregory J; Josiah S; Prorok JJ; Alhadeff JA
    Clin Chem; 1990 Jan; 36(1):161-2. PubMed ID: 2297916
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of sialic acid and alkaline DNase in breast cancer.
    Raval GN; Parekh LJ; Patel MM; Patel PS; Rawal RM; Balar DB; Patel DD
    Int J Biol Markers; 1997; 12(2):61-7. PubMed ID: 9342634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of serum markers in the diagnosis and management of laryngeal cancer.
    Mevio E; Benazzo M; Galioto P; Spriano P; Pizzala R
    Clin Otolaryngol Allied Sci; 1991 Feb; 16(1):90-2. PubMed ID: 2032368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid associated sialic acid in plasma in patients with advanced carcinoma of the ovaries.
    Vardi JR; Tadros GH; Malhotra C; Charney T; Shebes M; Foemmel R
    Surg Gynecol Obstet; 1989 Apr; 168(4):296-301. PubMed ID: 2928903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical application of serum levels of sialic acid, fucose and seromucoid fraction as tumour markers in human leukemias.
    Patel PS; Adhvaryu SG; Balar DB; Parikh BJ; Shah PM
    Anticancer Res; 1994; 14(2B):747-51. PubMed ID: 8010734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of serum CA-125 and lipid-associated sialic acid (LASA-P) in monitoring patients with invasive ovarian adenocarcinoma.
    Patsner B; Mann WJ; Vissicchio M; Loesch M
    Gynecol Oncol; 1988 May; 30(1):98-103. PubMed ID: 2452774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of lipid-bound sialic acid (LSA) as a tumor marker.
    López Sáez JJ; Senra-Varela A
    Int J Biol Markers; 1995; 10(3):174-9. PubMed ID: 8551061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total sialic acid as a tumor marker for oral cancer.
    Xing RD; Wang ZS; Li CQ; Tang QY; Jiang CB; Zhang YZ
    Int J Biol Markers; 1994; 9(4):239-42. PubMed ID: 7836802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating levels in serum of total sialic acid, lipid-associated sialic acid, and fucose in precancerous lesion and cancer of the oral cavity.
    Rao VR; Krishnamoorthy L; Kumaraswamy SV; Ramaswamy G
    Cancer Detect Prev; 1998; 22(3):237-40. PubMed ID: 9618045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evaluation of putative tumor markers for malignant melanoma.
    Reintgen DS; Cruse CW; Wells KE; Saba HI; Fabri PJ
    Ann Plast Surg; 1992 Jan; 28(1):55-9. PubMed ID: 1642407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of serum total lipid and free N-acetylneuraminic acid in genitourinary malignancies by fluorimetric high performance liquid chromatography. Relevance of free N-acetylneuraminic acid as tumour marker.
    Laganà A; Pardo-Martínez B; Marino A; Fago G; Bizzarri M
    Clin Chim Acta; 1995 Dec; 243(2):165-79. PubMed ID: 8747492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.